Ashley Hall - 03 Mar 2026 Form 4 Insider Report for Structure Therapeutics Inc. (GPCR)

Role
Chief Development Officer
Signature
/s/ Jun Yoon, Attorney-in-Fact
Issuer symbol
GPCR
Transactions as of
03 Mar 2026
Net transactions value
$0
Form type
4
Filing time
05 Mar 2026, 18:20:07 UTC
Previous filing
22 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hall Ashley Chief Development Officer C/O STRUCTURE THERAPEUTICS INC., 601 GATEWAY BLVD., SUITE 900, SOUTH SAN FRANCISCO /s/ Jun Yoon, Attorney-in-Fact 05 Mar 2026 0001801842

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GPCR Ordinary Shares Tax liability -4,836 -4.3% $20.99* 107,481 03 Mar 2026 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GPCR American Depositary Shares Award +225 $0.000000* 225 20 May 2025 Ordinary Shares 675 Direct F1, F3, F4
transaction GPCR American Depositary Shares Award +237 +105% $0.000000* 462 20 Nov 2025 Ordinary Shares 711 Direct F1, F3, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer.
F2 Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award.
F3 Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date.
F4 Voluntary reporting of the acquisition of 225 ADSs by the Reporting Person on May 20, 2025 pursuant to the Issuer's Employee Share Purchase Plan.
F5 Voluntary reporting of the acquisition of 237 ADSs by the Reporting Person on November 20, 2025 pursuant to the Issuer's Employee Share Purchase Plan.